Sengal, A.T.; Smith, D.; Rogers, R.; Snell, C.E.; Williams, E.D.; Pollock, P.M.
Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer. Cancers 2021, 13, 1703.
https://doi.org/10.3390/cancers13071703
AMA Style
Sengal AT, Smith D, Rogers R, Snell CE, Williams ED, Pollock PM.
Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer. Cancers. 2021; 13(7):1703.
https://doi.org/10.3390/cancers13071703
Chicago/Turabian Style
Sengal, Asmerom T., Deborah Smith, Rebecca Rogers, Cameron E. Snell, Elizabeth D. Williams, and Pamela M. Pollock.
2021. "Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer" Cancers 13, no. 7: 1703.
https://doi.org/10.3390/cancers13071703
APA Style
Sengal, A. T., Smith, D., Rogers, R., Snell, C. E., Williams, E. D., & Pollock, P. M.
(2021). Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer. Cancers, 13(7), 1703.
https://doi.org/10.3390/cancers13071703